Presentation TCT 2016 Future TAVR Devices and Adjunctive Therapies Presenter: Blase A. Carabello, George D. Dangas November 01, 2016
Presentation TCT 2016 The Case for Sutureless/ Rapid Deployment Valves Presenter: Michael A. Borger, Vinod H. Thourani November 01, 2016
Presentation TCT 2016 Technical and Clinical Considerations of ASD Closure in the Elderly Presenter: Lee N. Benson, Ziyad M. Hijazi, Damien P. Kenny November 01, 2016
Presentation TCT 2016 TAVR: Current Status of Devices and Indications Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani November 01, 2016
Presentation TCT 2016 The Case for TAVR Presenter: Michael A. Borger, Vinod H. Thourani, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Echocardiographic Assessment of the Atrial Septum Presenter: Lee N. Benson, Ziyad M. Hijazi, Craig E Fleishman November 01, 2016
News Conference News TCT 2016 Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention Yael L. Maxwell November 01, 2016
Presentation TCT 2016 Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients! Presenter: Andreas Baumbach, David Hildick-Smith, Jai-Wun Park November 01, 2016
Presentation TCT 2016 Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!) Presenter: Andreas Baumbach, David Hildick-Smith, Ted Feldman November 01, 2016
Presentation TCT 2016 Planning and Performing TAVR in the Patient With CKD Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta November 01, 2016
Presentation TCT 2016 RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients! Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy! Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen November 01, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
News Conference News TCT 2016 TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function Todd Neale November 01, 2016
Presentation TCT 2016 Venezuela Presents: A Case of a TAVR Complication Presenter: Juan F. Granada, Oscar A. Mendiz, Carlos D Calderas November 01, 2016
Presentation TCT 2016 Argentina Presents: A Case of a TAVR Complication Presenter: Juan F. Granada, Oscar A. Mendiz November 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
Presentation TCT 2016 PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas November 01, 2016